Amiodarone Pulmonary Toxicity After Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 9, 2008, Pages 1059-1063

  Diaz Guzman, Enrique ^a   Mireles Cabodevila, Eduardo ^a   Arrossi, Andrea ^a   Kanne, Jeffrey P ^a   Budev, Marie ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CORTICOSTEROID; DILTIAZEM;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DRUG DOSE INCREASE; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; LUNG DEPOSIT; LUNG FUNCTION TEST; LUNG TOXICITY; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIODIAGNOSIS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PLEURAL EFFUSION; PNEUMONIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 50249154766     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.05.023     Document Type: Article

References (25)

1. Chung M.K. Cardiac surgery: postoperative arrhythmias. Crit Care Med 28 (2000) N136-N144
2. Ommen S.R., Odell J.A., and Stanton M.S. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997) 1429-1434
3. Aranki S.F., Shaw D.P., Adams D.H., et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94 (1996) 390-397
4. Mason D.P., Marsh D.H., Alster J.M., et al. Atrial fibrillation after lung transplantation: timing, risk factors, and treatment. Ann Thorac Surg 84 (2007) 1878-1884
5. Nielsen T.D., Bahnson T., Davis R.D., and Palmer S.M. Atrial fibrillation after pulmonary transplant. Chest 126 (2004) 496-500
6. Roy D., Talajic M., Dorian P., et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342 (2000) 913-920
7. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 42 (2003) 20-29
8. Martinez E.A., Bass E.B., and Zimetbaum P. Pharmacologic control of rhythm: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 suppl (2005) 48S-55S
9. Rotmensch H.H., Liron M., Tupilski M., and Laniado S. Possible association of pneumonitis with amiodarone therapy. Am Heart J 100 (1980) 412-413
10. Martin II W.J., and Rosenow III E.C. Amiodarone pulmonary toxicity. Recognition and pathogenesis. Chest 93 (1988) 1067-1075
11. Fraire A.E., Guntupalli K.K., Greenberg S.D., Cartwright Jr. J., and Chasen M.H. Amiodarone pulmonary toxicity: a multidisciplinary review of current status. South Med J 86 (1993) 67-77
12. Biour M., Hugues F.C., Hamel J.D., and Cheymol G. Adverse pulmonary effects of amiodarone. Analysis of 162 cases [in French]. Therapie 40 (1985) 343-348
13. Camus P., Martin II W.J., and Rosenow III E.C. Amiodarone pulmonary toxicity. Clin Chest Med 25 (2004) 65-75
14. Jessurun G.A., Boersma W.G., and Crijns H.J. Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment. Drug Safety 18 (1998) 339-344
15. Morady F., Sauve M.J., Malone P., et al. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol 52 (1983) 975-979
16. Ott M.C., Khoor A., Leventhal J.P., Paterick T.E., and Burger C.D. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 123 (2003) 646-651
17. Xaubet A., Roca J., Rodriguez-Roisin R., et al. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis. Respiration 52 (1987) 272-280
18. Myers J.L., Kennedy J.I., and Plumb V.J. Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 18 (1987) 349-354
19. Leslie K.O., and Wick M.R. Practical pulmonary pathology: a diagnostic approach (2005), Churchill Livingstone, Philadelphia
20. Adams P.C., Holt D.W., Storey G.C., et al. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation 72 (1985) 1064-1075
21. Siniakowicz R.M., Narula D., Suster B., and Steinberg J.S. Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J Cardiovasc Electrophysiol 12 (2001) 431-436
22. Marchlinski F.E., Gansler T.S., Waxman H.L., and Josephson M.E. Amiodarone pulmonary toxicity. Ann Intern Med 97 (1982) 839-845
23. Gonzalez-Rothi R.J., Hannan S.E., Hood C.I., and Franzini D.A. Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions. Chest 92 (1987) 179-182
24. Clarke B., Ward D.E., and Honey M. Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. Int J Cardiol 8 (1985) 81-88
25. Ferrer J., Roldan J., Roman A., et al. Acute and chronic pleural complications in lung transplantation. J Heart Lung Transplant 22 (2003) 1217-1225